[Federal Register Volume 87, Number 65 (Tuesday, April 5, 2022)]
[Notices]
[Pages 19668-19669]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-07150]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee meeting

AGENCY: Under Secretary of Defense for Personnel and Readiness, 
Department of Defense (DoD).

ACTION: Notice of Federal Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY: The DoD is publishing this notice to announce that the 
following Federal Advisory Committee meeting of the Uniform Formulary 
Beneficiary Advisory Panel (UF BAP) will take place.

DATES: Open to the public Wednesday, April 6, 2022, 10:00 a.m.-1:00 
p.m. (Eastern Standard Time).

ADDRESSES: The meeting will be held telephonically or via conference 
call. The phone number for the remote access on April 6, 2022 is: 
CONUS: 1-800-369-2046; OCONUS: 1-203-827-7030; PARTICIPANT CODE: 
8546285.
    These numbers and the dial-in instructions will also be posted on 
the Uniform Formulary Beneficiary Advisory Panel Website at: https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP.

FOR FURTHER INFORMATION CONTACT: Designated Federal Official (DFO) 
Colonel Paul J. Hoerner, USAF, 703-681-2890 (voice), <a href="/cdn-cgi/l/email-protection#a8ccc0c986c6cbda86c2859e86c5cad086cac9d8dacdd9ddcddbdcdbe8c5c9c1c486c5c1c4"><span class="__cf_email__" data-cfemail="eb8f838ac5858899c581c6ddc5868993c5898a9b998e9a9e8e989f98ab868a8287c5868287">[email protected]</span></a> (email). Mailing address is 7700 Arlington 
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP. The most up-to-date changes to the meeting 
agenda can be found on the website.

SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of 
the DoD and the DFO, the UF BAP was unable to provide public 
notification required by 41 CFR 102-3.150(a) concerning its April 6, 
2022 meeting of the UF BAP. Accordingly, the Advisory Committee 
Management Officer for the DoD, pursuant to 41 CFR 102-3.150(b), waives 
the 15-calendar day notification requirement.
    This meeting is being held under the provisions of the Federal 
Advisory Committee Act (FACA) (5 U.S.C., appendix) and 41 CFR 102-3.140 
and 102-3.150.
    Purpose of the Meeting: The Panel will review and comment on 
recommendations made to the Director, Defense Health Agency, by the 
Pharmacy and Therapeutics Committee, regarding the Uniform Formulary.

Agenda

1. 10:00 a.m.-10:10 a.m. Sign In for UF BAP members
2. 10:10 a.m.-10:40 a.m. Welcome and Opening Remarks
    a. Welcome, Opening Remarks, and Introduction of UF BAP Members 
by Col Paul J. Hoerner, DFO, UF BAP
    b. Opening Remarks by UF BAP Co-Chair Senior Chief Petty Officer 
Jon R. Ostrowski, Non-Commissioned Officers Association
    c. Introductory Remarks by CDR Scott Raisor, Interim Chief, 
Formulary Management Branch
    d. Public Written Comments by CDR Raisor
3. 10:40 a.m.-11:45 a.m. Scheduled Therapeutic Class Reviews
    a. Oncological Agents: Renal Cell Carcinoma; Myelofibrosis; 
Epidermal Growth Factor Receptor (EGFR) plus Non-Small Cell Lung 
Cancer (NSCLC); Non-Bruton's Tyrosine Kinase Inhibitor (Non-BTKI) 
for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma 
(SLL); and Poly Adenosine Diphosphate-Ribose (PARP) Inhibitors 
subclasses
    b. Binders-Chelators-Antidotes-Overdose Agents: Hypoglycemia 
Agents
4. 11:45 a.m.-12:30 p.m. Newly Approved Drugs Review
5. 12:30 p.m.-12:45 p.m. Pertinent

[[Page 19669]]

Utilization Management Issues
    * Note that UF BAP discussion and vote will follow each section
6. 12:45 p.m.-1:00 p.m. Closing remarks
    a. Closing Remarks by UF BAP Co-Chair Senior Chief Petty Officer 
Jon R. Ostrowski
    b. Closing Remarks by Col Paul J Hoerner, DFO, UF BAP

    Meeting Accessibility: Pursuant to section 10(a)(1) of the FACA and 
41 CFR 102-3.140 through 102-3.165, and subject to the availability of 
phone lines, this meeting is open to the public. Telephone lines are 
limited and available to the first 220 people dialing in. There will be 
220 lines total: 200 domestic and 20 international, including leader 
lines.
    Written Statements: Pursuant to 41 CFR 102-3.10, and section 
10(a)(3) of FACA, interested persons or organizations may submit 
written statements to the UF BAP about its mission and/or the agenda to 
be addressed in this public meeting. Written statements should be 
submitted to the Uniform Formulary Beneficiary Advisory Panel's DFO. 
The DFO's contact information can be found in the FOR FURTHER 
INFORMATION CONTACT section of this notice. Written comments or 
statements must be received by the UF BAP's DFO at least one (1) 
calendar day prior to the meeting so they may be made available to the 
UF BAP for its consideration prior to the meeting. The DFO will review 
all submitted written statements and provide copies to UF BAP.

    Dated: March 30, 2022.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2022-07150 Filed 4-4-22; 8:45 am]
BILLING CODE 5001-06-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>